TrialDiabetologia2005

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.

B Charbonnel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.